Trends & Forecasts

An FDA Warning Letter can be a real wake up call. How can you address the root of the problem?

Sitting Down With… Wim Leereveld, founder and CEO of the Access to Medicine Foundation

Maximizing operational excellence – what have we learned and where do we go next?

Today’s pharmaceutical manufacturing operations capture huge amounts of data. Unfortunately, in many cases the data pass by without actual context.

The World Health Organization has compiled a list of 17 tropical diseases that deserve higher priority.

Lilly and Sanofi go head-to-head on a diabetes drug. Meanwhile, Hospira sues the FDA over a new generic approval.

How are changing trends and fresh challenges affecting the world of medicine manufacture?

If you work in the development or manufacture of drugs and biologics – this is your magazine.